140 related articles for article (PubMed ID: 34774868)
21. Individualised target volume selection and dose prescription after conservative surgery, mastectomy and reconstruction.
Chua BH
Breast; 2019 Nov; 48 Suppl 1():S69-S75. PubMed ID: 31839165
[TBL] [Abstract][Full Text] [Related]
22. Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity.
Chitapanarux I; Klunklin P; Pinitpatcharalert A; Sripan P; Tharavichitkul E; Nobnop W; Onchan W; Chakrabandhu S; Jia-Mahasap B; Euathrongchit J; Wannasopha Y; Srisuwan T
Radiat Oncol; 2019 Oct; 14(1):175. PubMed ID: 31610801
[TBL] [Abstract][Full Text] [Related]
23. A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer.
Lee SW; Kim YJ; Shin KH; Kim K; Chie EK; Han W; Im SA; Jung SY; Lee KS; Lee ES
Medicine (Baltimore); 2016 May; 95(19):e3320. PubMed ID: 27175630
[TBL] [Abstract][Full Text] [Related]
24. Hypofractionated volumetric-modulated arc therapy for breast cancer: A propensity-score-weighted comparison of radiation-related toxicity.
Kim N; Chang JS; Shah C; Shin H; Keum KC; Suh CO; Kim YB
Int J Cancer; 2021 Jul; 149(1):149-157. PubMed ID: 33600612
[TBL] [Abstract][Full Text] [Related]
25. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.
Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N
Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964
[TBL] [Abstract][Full Text] [Related]
26. Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors.
Ciammella P; Podgornii A; Galeandro M; Micera R; Ramundo D; Palmieri T; Cagni E; Iotti C
Radiat Oncol; 2014 Apr; 9():97. PubMed ID: 24762173
[TBL] [Abstract][Full Text] [Related]
27. Utilization of Hypofractionated Whole-Breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.
Sayan M; Vergalasova I; Jhawar S; Kumar S; George M; Kowzun M; Potdevin L; Toppmeyer D; Haffty B; Ohri N
Clin Breast Cancer; 2021 Feb; 21(1):31-36. PubMed ID: 32792224
[TBL] [Abstract][Full Text] [Related]
28. Quantitative Assessment of Breast Cosmetic Outcome After Whole-Breast Irradiation.
Reddy JP; Lei X; Huang SC; Nicklaus KM; Fingeret MC; Shaitelman SF; Hunt KK; Buchholz TA; Merchant F; Markey MK; Smith BD
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):894-902. PubMed ID: 28333010
[TBL] [Abstract][Full Text] [Related]
29. An accelerated hypofractionated schedule with a daily concomitant boost after breast conservation surgery: the feasibility and toxicity.
Ghannam AA; Khedr RA
J Egypt Natl Canc Inst; 2016 Mar; 28(1):39-44. PubMed ID: 26833225
[TBL] [Abstract][Full Text] [Related]
30. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
31. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.
Doré M; Cutuli B; Cellier P; Campion L; Le Blanc M
Radiat Oncol; 2015 Aug; 10():161. PubMed ID: 26238442
[TBL] [Abstract][Full Text] [Related]
32. Breast Conserving Therapy for Patients With Prior Cosmetic Implant-Based Breast Augmentation: Outcomes and Comparison Against a Matched Cohort.
Grzywacz VP; Lehrberg AV; Quinn TJ; Zureick AH; Sarvepalli N; Oliver LN; Dekhne NS; Dilworth JT
Clin Breast Cancer; 2024 Apr; 24(3):227-236. PubMed ID: 38185608
[TBL] [Abstract][Full Text] [Related]
33. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
[No Abstract] [Full Text] [Related]
34. Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
Deshmukh AA; Shirvani SM; Lal L; Swint JM; Cantor SB; Smith BD; Likhacheva A
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059428
[TBL] [Abstract][Full Text] [Related]
35. Toxicity and clinical outcomes of partial breast irradiation compared to whole breast irradiation for early-stage breast cancer: a systematic review and meta-analysis.
Korzets Y; Fyles A; Shepshelovich D; Amir E; Goldvaser H
Breast Cancer Res Treat; 2019 Jun; 175(3):531-545. PubMed ID: 30929116
[TBL] [Abstract][Full Text] [Related]
36. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
Aluwini S; Pos F; Schimmel E; van Lin E; Krol S; van der Toorn PP; de Jager H; Dirkx M; Alemayehu WG; Heijmen B; Incrocci L
Lancet Oncol; 2015 Mar; 16(3):274-83. PubMed ID: 25656287
[TBL] [Abstract][Full Text] [Related]
37. Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPAB Trial).
Franceschini D; Loi M; Chiola I; Arculeo S; Marzo M; Fernandes B; Masci G; Torrisi R; Tinterri C; Testori A; Santoro A; Scorsetti M
Clin Breast Cancer; 2021 Jun; 21(3):231-238. PubMed ID: 33121891
[TBL] [Abstract][Full Text] [Related]
38. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
[TBL] [Abstract][Full Text] [Related]
39. Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort.
Jagsi R; Griffith KA; Boike TP; Walker E; Nurushev T; Grills IS; Moran JM; Feng M; Hayman J; Pierce LJ
JAMA Oncol; 2015 Oct; 1(7):918-30. PubMed ID: 26247417
[TBL] [Abstract][Full Text] [Related]
40. Hypofractionation for clinically localized prostate cancer.
Hickey BE; James ML; Daly T; Soh FY; Jeffery M
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011462. PubMed ID: 31476800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
